Literature DB >> 25534505

IBS in 2014: Developments in pathophysiology, diagnosis and management.

Peter J Whorwell1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25534505     DOI: 10.1038/nrgastro.2014.225

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis.

Authors:  Christoph A Thaiss; David Zeevi; Maayan Levy; Gili Zilberman-Schapira; Jotham Suez; Anouk C Tengeler; Lior Abramson; Meirav N Katz; Tal Korem; Niv Zmora; Yael Kuperman; Inbal Biton; Shlomit Gilad; Alon Harmelin; Hagit Shapiro; Zamir Halpern; Eran Segal; Eran Elinav
Journal:  Cell       Date:  2014-10-16       Impact factor: 41.582

2.  Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.

Authors:  Ming-Hui Chang; Jen-Wei Chou; Shan-Ming Chen; Ming-Chang Tsai; Yu-Shu Sun; Chun-Che Lin; Ching-Pin Lin
Journal:  Mol Med Rep       Date:  2014-04-24       Impact factor: 2.952

3.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

4.  Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology.

Authors:  R L Levy; K R Jones; W E Whitehead; S I Feld; N J Talley; L A Corey
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

Review 5.  The burden of IBS: looking at metrics.

Authors:  Brennan M R Spiegel
Journal:  Curr Gastroenterol Rep       Date:  2009-08

6.  Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS.

Authors:  Antal Bajor; Hans Törnblom; Mats Rudling; Kjell-Arne Ung; Magnus Simrén
Journal:  Gut       Date:  2014-04-12       Impact factor: 23.059

7.  Diets that differ in their FODMAP content alter the colonic luminal microenvironment.

Authors:  Emma P Halmos; Claus T Christophersen; Anthony R Bird; Susan J Shepherd; Peter R Gibson; Jane G Muir
Journal:  Gut       Date:  2014-07-12       Impact factor: 23.059

8.  The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study.

Authors:  Laura Rindom Krogsgaard; Anne Line Engsbro; Christen Rune Stensvold; Henrik Vedel Nielsen; Peter Bytzer
Journal:  Clin Gastroenterol Hepatol       Date:  2014-09-16       Impact factor: 11.382

9.  Faecal incontinence-the hidden scourge of irritable bowel syndrome: a cross-sectional study.

Authors:  Sima Atarodi; Shahram Rafieian; Peter J Whorwell
Journal:  BMJ Open Gastroenterol       Date:  2015-02-06

10.  Psychosocial stress in nurses with shift work schedule is associated with functional gastrointestinal disorders.

Authors:  Seong-Joon Koh; Mingoo Kim; Da Yeon Oh; Byeong Gwan Kim; Kook Lae Lee; Ji Won Kim
Journal:  J Neurogastroenterol Motil       Date:  2014-09-19       Impact factor: 4.924

  10 in total
  4 in total

1.  Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls.

Authors:  Robyn Nagel; Rebecca J Traub; Marcella M S Kwan; Helle Bielefeldt-Ohmann
Journal:  Parasit Vectors       Date:  2015-09-15       Impact factor: 3.876

Review 2.  Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside.

Authors:  Lei Zhang; Jun Song; Xiaohua Hou
Journal:  J Neurogastroenterol Motil       Date:  2016-04-30       Impact factor: 4.924

3.  Re: A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome.

Authors:  Laura Appleton; Andrew S Day
Journal:  J Clin Med       Date:  2019-11-06       Impact factor: 4.241

4.  Neuro-Immune Modulation Effects of Sacral Nerve Stimulation for Visceral Hypersensitivity in Rats.

Authors:  Xue Jin; Payam Gharibani; Jieyun Yin; Jiande D Z Chen
Journal:  Front Neurosci       Date:  2021-07-02       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.